Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 182

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy

Riggs, J. E., Apfel, S. C., Litchy, W. J., Kessler, J. A., Sanders, C., Adornato, B. T., Rask, C. A.·1999·Neurology

Abstract

To the Editor: The article by Apfel et al. concerning recombinant human nerve growth factor (rhNGF) in the treatment of diabetic polyneuropathy (DPN) highlights the dilemma facing many clinical trials dealing with degenerative neurologic disease.1 Although rhNGF may have some beneficial therapeutic effect in DPN, rhNGF has little chance of gaining sustained widespread clinical acceptance if the beneficial effect can only be demonstrated by various combinations of multiple endpoints that are individually, not statistically or clinically, significant. Patients and treating physicians need to “see” the benefit. Indeed, the clinical utility of some of the endpoints are vague. For example, one endpoint in this rhNGF clinical trial was the Neuropathy Impairment Lower Limbs (NISLL) score.1 The NISLL score is compiled from the grading of strength, sensation, and reflexes; the obtained score is then “normalized, in the mind of the examiner, for site, age, gender, height, weight, and physical fitness.”2 What does a NISLL score obtained in such a manner from the “mind of the examiner” actually signify? As the authors …

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.52.7.1517-a

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 182

Metadata

Authors
Riggs, J. E., Apfel, S. C., Litchy, W. J., Kessler, J. A., Sanders, C., Adornato, B. T., & Rask, C. A.
Venue
Neurology
Published
1999-04-01
Volume
52
Issue
7
Pages
1517-1517
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2065662892
Cited by
182
References
2
FWCI
11.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. https://app.cochat.ai/papers/10.1212/wnl.52.7.1517-a
The paper
Riggs, J. E., Apfel, S. C., Litchy, W. J., Kessler, J. A., Sanders, C., Adornato, B. T., & Rask, C. A. (1999). Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology. https://doi.org/10.1212/wnl.52.7.1517-a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.